UK fillip for Bracco as NICE voices resounding support for SonoVue
This article was originally published in Clinica
Bracco Diagnostics’ SonoVue imaging agent has been thrust into mainstream UK liver care protocols after the National Institute for Heath and Clinical Excellence (NICE) issued a resoundingly positive appraisal of the ultrasound-enhancing technology’s capacity to diagnose and investigate primary and secondary cancers and cirrhosis.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.